His primary scientific interests are in Breast cancer, Genetics, Cancer, Internal medicine and Oncology. His study in Breast cancer is interdisciplinary in nature, drawing from both Ovarian cancer and Genome-wide association study, Genotype, Single-nucleotide polymorphism. Dominique Stoppa-Lyonnet combines subjects such as Gynecology, Serous fluid and Family history with his study of Ovarian cancer.
His Cancer research includes elements of Odds ratio, Genetic counseling, Cancer research and Endocrinology. His research on Internal medicine focuses in particular on Risk factor. The study incorporates disciplines such as Cohort study, Immunology, Gene mutation, Ataxia-telangiectasia and Hazard ratio in addition to Oncology.
His main research concerns Breast cancer, Genetics, Internal medicine, Oncology and Cancer. His Breast cancer study combines topics in areas such as Germline mutation, Cancer research, Mutation, Ovarian cancer and Genotype. His study in Gene, Allele, Mutation, Germline and Exon falls within the category of Genetics.
Internal medicine is often connected to Pathology in his work. His Oncology study incorporates themes from Genetic predisposition, Ataxia-telangiectasia, Hazard ratio, Family history and Cohort. Dominique Stoppa-Lyonnet has researched Cancer in several fields, including Genetic counseling, Gynecology and Genetic testing.
His primary areas of study are Breast cancer, Internal medicine, Oncology, Genetics and Cancer. The Breast cancer study combines topics in areas such as Prospective cohort study, Genome-wide association study, FANCM and Mutation. His Oncology research incorporates elements of Germline mutation, Single-nucleotide polymorphism, Genotype, Hazard ratio and Family history.
His Genetics study frequently links to related topics such as Disease. His research in the fields of Hereditary Breast Cancer overlaps with other disciplines such as Context. His work is dedicated to discovering how Gene, Cancer research are connected with Cell, DICER1 Syndrome and microRNA and other disciplines.
Dominique Stoppa-Lyonnet mainly investigates Breast cancer, Genetics, Computational biology, splice and Genetic analysis. His Breast cancer study introduces a deeper knowledge of Internal medicine. His studies in Computational biology integrate themes in fields like DNA binding site, Transcription factor, Genetic association, In silico and DNA sequencing.
The various areas that Dominique Stoppa-Lyonnet examines in his Genetic analysis study include Multifactorial Inheritance, Genetic variability, Mutation and Medical genetics. Dominique Stoppa-Lyonnet focuses mostly in the field of Oncology, narrowing it down to matters related to Hazard ratio and, in some cases, Single-nucleotide polymorphism. His research investigates the connection between Risk factor and topics such as Cancer research that intersect with issues in CHEK2.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1.
S. Hacein-Bey-Abina;C. Von Kalle;C. Von Kalle;M. Schmidt;M. P. McCormack.
Genetic Heterogeneity and Penetrance Analysis of the BRCA1 and BRCA2 Genes in Breast Cancer Families
D Ford;D F Easton;M Stratton;S Narod.
American Journal of Human Genetics (1998)
Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers
Karoline B. Kuchenbaecker;Karoline B. Kuchenbaecker;John L. Hopper;Daniel R. Barnes;Kelly-Anne Phillips.
The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds.
S.V. Tavtigian;J. Simard;J. Rommens;F. Couch.
Nature Genetics (1996)
Multifactorial Analysis of Differences Between Sporadic Breast Cancers and Cancers Involving BRCA1 and BRCA2 Mutations
Sunil R. Lakhani;Jocelyne Jacquemier;John P Sloane;Barry A. Gusterson.
Journal of the National Cancer Institute (1998)
Salpingo-oophorectomy and the Risk of Ovarian, Fallopian Tube, and Peritoneal Cancers in Women With a BRCA1 or BRCA2 Mutation
Amy Finch;Mario Beiner;Jan Lubinski;Henry T. Lynch.
Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study
Steven A. Narod;Jean Sébastien Brunet;Parviz Ghadirian;Mark Robson.
The Lancet (2000)
Protein interaction mapping: A Drosophila case study
Etienne Formstecher;Sandra Aresta;Vincent Collura;Alexandre Hamburger.
Genome Research (2005)
Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA).
Nasim Mavaddat;Daniel Barrowdale;Irene L. Andrulis;Susan M. Domchek.
Cancer Epidemiology, Biomarkers & Prevention (2012)
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer
Stig E. Bojesen;Stig E. Bojesen;Karen A. Pooley;Sharon E. Johnatty;Jonathan Beesley.
Nature Genetics (2013)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: